The coexpression of members of the EGFR family underlines their role in the oncogenesis of anaplastic astrocytomas and supports their promising clinical relevance in regard to prognosis, diagnosis, and therapy. The gene discussed is EGFR; the disease is anaplastic astrocytoma.